Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
URGN - As of  05/28/20, 10:52:00 AM:   24 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Institutional Transactions for URGN

                Buy: Blue    Sell: Red
Non-meaningful transactions (gifts, grants, etc.) are automatically filtered out for quicker actions.
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
S 2020-05-20 2020-05-20 16:45:22.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 358 $25.07 $8,975.06 7,079 view
S 2020-04-27 2020-04-28 13:53:46.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 70 $24.35 $1,704.50 17,711 view
S 2020-04-27 2020-04-28 13:52:01.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 141 $24.35 $3,433.35 6,396 view
S 2020-04-27 2020-04-28 13:44:27.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 145 $24.35 $3,530.75 10,084 view
S 2020-02-20 2020-02-24 16:54:08.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 360 $29.68 $10,684.80 6,120 view
S 2020-02-14 2020-02-18 14:34:09.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 612 $28.04 $17,160.50 9,812 view
S 2020-01-27 2020-01-28 17:16:23.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 667 $29.28 $19,529.80 4,438 view
S 2020-01-27 2020-01-28 17:14:41.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 684 $29.26 $20,013.80 8,665 view
S 2020-01-27 2020-01-28 17:11:25.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 322 $29.15 $9,386.30 9,177 view
P 2019-11-21 2019-11-22 15:35:12.0 UroGen Pharma Ltd. URGN Barrett Elizabeth A. CEO 7,530 $28.00 $210,840.00 16,548 view
P 2019-11-20 2019-11-22 13:36:02.0 UroGen Pharma Ltd. URGN Barrett Elizabeth A. CEO 7,470 $28.00 $209,160.00 9,018 view
S 2019-11-20 2019-11-22 13:30:07.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 354 $28.41 $10,057.10 3,439 view
P 2019-11-19 2019-11-21 20:49:44.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 1,960 $28.17 $55,213.20 7,967 view
P 2019-11-15 2019-11-18 19:34:02.0 UroGen Pharma Ltd. URGN Barrett Elizabeth A. CEO 1,548 $26.00 $40,248.00 1,548 view
S 2019-11-14 2019-11-18 16:05:06.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 608 $26.00 $15,806.40 7,683 view
S 2019-09-04 2019-09-06 09:29:00.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 343 $33.92 $11,634.60 6,007 view
S 2019-08-20 2019-08-22 13:32:27.0 UroGen Pharma Ltd. URGN PFREUNDSCHUH PETER P. officer (Chief Financial Officer) 1,416 $33.07 $46,827.10 2,751 view
S 2019-08-15 2019-08-16 15:39:21.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 608 $31.65 $19,243.20 6,532 view
S 2019-05-14 2019-05-16 18:20:48.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 608 $37.98 $23,091.80 5,381 view
P 2019-03-21 2019-03-22 19:43:28.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 272 $37.01 $10,066.40 4,610 view
S 2019-03-06 2019-03-07 21:47:35.0 UroGen Pharma Ltd. URGN Schoenberg Mark officer (Chief Medical Officer) 1,991 $37.30 $74,264.30 4,338 view
S 2019-02-14 2019-03-07 21:45:19.0 UroGen Pharma Ltd. URGN Mullennix Stephen officer (Chief Operating Officer) 2,804 $37.30 $104,589.00 4,230 view
S 2017-11-28 2017-11-29 17:08:03.0 UroGen Pharma Ltd. URGN SCHREIBER ALAIN various various various 10% owner 177,807 $40.51 $7,202,960.00 1,242,030 view
S 2017-11-27 2017-11-29 17:08:03.0 UroGen Pharma Ltd. URGN SCHREIBER ALAIN various various various 10% owner 31,491 $41.12 $1,294,910.00 1,419,840 view
* An * after P or S in the Buy/Sell column means the transaction was filed by the insider as open market, but it was marked as private transaction by insidercow's proprietary method
Enter Another Stock Symbol: